A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia

NCT06238466 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular

Interventions

DRUG: AZD1705
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]